Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeKCIAcelity Announces Enhancements to V.A.C.ULTA™ Therapy System

Acelity Announces Enhancements to V.A.C.ULTA™ Therapy System

April 13, 2017

Acelity, a global advanced wound care company, today announced that two significant enhancements to the V.A.C.ULTA™ Therapy System are now available in the U.S. The V.A.C.ULTA™ Therapy System, Acelity’s latest generation negative pressure wound therapy (NPWT) system, is now enhanced to improve clinicians’ experiences by leveraging first-to-market connectivity technology.

Acelity notes the iOn RESULTS™ Remote Therapy Monitoring (RTM) connects hospitals to Acelity’s unique service and support offering to promote compliance and drive proper patient utilization of therapy. The V.A.C.ULTA™ 4 Therapy System simplifies functionality, reports summative therapy, and allows for on-screen selection of four different therapies on a single advanced device which can be tailored to a patient’s specific need and clinician’s preference. Designed with outcomes and experience in mind, these enhancements combine Acelity’s expertise in advanced wound care with the latest in technology to provide greater accuracy and certainty for clinicians with the goal of improving outcomes for patients while lowering costs.

“Acelity is leading the transformation to value-based care by enhancing our best-in-class advanced therapies with improvements that take into account the experiences of our customers who are on the front line in treating patients,” said R. Andrew Eckert, president and chief executive officer of Acelity. “The V.A.C.ULTA™ System has an unmatched reputation in hospitals for delivering the best outcomes for wounds, and with these new features, we can better support doctors and nurses by providing real-time monitoring and data to enhance care delivery.”

iOn RESULTS™ Remote Therapy Monitoring works in conjunction with the V.A.C.ULTA™ Therapy System to monitor the therapy units’ performance in the hospital setting. The system enables timely feedback and therapy application optimization to enhance product performance metrics to identify hospital staff training or support needs.

V.A.C.ULTA™ 4 Therapy System provides simplified functionality through a software upgrade that provides enhanced pathways to the device’s four negative pressure therapies: V.A.C.® Therapy, V.A.C. VERAFLO™ Therapy, PREVENA™ Therapy and ABTHERA™ Therapy. The new system provides a device that allows usage of the four different therapies that can be tailored depending on a patient’s need and the clinician’s varying levels of experience. Therapy setup pathways for each therapy have shown significant reduction in numbers of screens and button pushes, saving clinicians’ time. For example, V.A.C. VERAFLO™ Therapy can now be initiated with 38 percent fewer steps.

“By simplifying functionality and making their products and therapies more approachable in daily use, Acelity continues to demonstrate an understanding of the burdens we face, which continue to change in an increasingly complex healthcare landscape,” said Elizabeth McElroy, Certified Wound Ostomy Continence Nurse (CWOCN) at Reading Hospital. “These new features are the latest example of how Acelity innovation allows us to focus on our most important job – taking care of people.”

The new V.A.C.ULTA™ Therapy System enhancements were developed with day-to-day challenges faced by clinicians, administrators and patients in mind. Acelity also recently added FISTULA SOLUTION® Devices to help clinicians manage patients with fistula complications. Managing wounds in patients with fistulas is challenging and represented a significant unmet need. These devices provide nurses with a solution to divert fistula effluent away from surrounding tissue, and are used in conjunction with wound management plans ordered by the clinicians.

About V.A.C.ULTA™ Therapy System

The V.A.C.ULTA™ System is Acelity’s latest generation negative pressure wound therapy device designed to deliver the proven wound healing benefits of V.A.C.® Therapy. Only V.A.C.® Therapy provides patented SENSAT.R.A.C.™ Technology, a real-time pressure feedback system that adjusts pump output, compensating for wound distance, wound position, exudate characteristics, and patient movement. Please refer to the Instructions for Use for the V.A.C.ULTA™ Therapy System for a complete list of appropriate uses, warnings, and precautions.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy